Found: 59
Select item for more details and to access through your institution.
Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy.
- Published in:
- European Journal of Immunology, 2015, v. 45, n. 1, p. 49, doi. 10.1002/eji.201444722
- By:
- Publication type:
- Article
Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32567-8
- By:
- Publication type:
- Article
A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Serial immunomonitoring of cancer patients receiving combined antagonistic anti-CD40 and chemotherapy reveals consistent and cyclical modulation of T cell and dendritic cell parameters.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comprehensive Testing of Chemotherapy and Immune Checkpoint Blockade in Preclinical Cancer Models Identifies Additive Combinations.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.872295
- By:
- Publication type:
- Article
Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma.
- Published in:
- PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0274364
- By:
- Publication type:
- Article
The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.
- Published in:
- Nature Genetics, 2011, v. 43, n. 7, p. 668, doi. 10.1038/ng.855
- By:
- Publication type:
- Article
Chemotherapy Enhances Cross-Presentation of Nuclear Tumor Antigens.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0107894
- By:
- Publication type:
- Article
Statins Do Not Alter the Incidence of Mesothelioma in Asbestos Exposed Mice or Humans.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0103025
- By:
- Publication type:
- Article
Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0061895
- By:
- Publication type:
- Article
Cyclophosphamide Chemotherapy Sensitizes Tumor Cells to TRAIL-Dependent CD8 T Cell-Mediated Immune Attack Resulting in Suppression of Tumor Growth.
- Published in:
- PLoS ONE, 2009, v. 4, n. 9, p. 1, doi. 10.1371/journal.pone.0006982
- By:
- Publication type:
- Article
Contribution of the immune system to the chemotherapeutic response.
- Published in:
- Seminars in Immunopathology, 2011, v. 33, n. 4, p. 353, doi. 10.1007/s00281-011-0246-z
- By:
- Publication type:
- Article
Serologic Responses in Patients with Malignant Mesothelioma.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2000, v. 22, n. 5, p. 550, doi. 10.1165/ajrcmb.22.5.3930
- By:
- Publication type:
- Article
Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis.
- Published in:
- Respiratory Research, 2001, v. 2, p. 119, doi. 10.1186/rr46
- By:
- Publication type:
- Article
Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3249, doi. 10.1007/s00262-021-02934-3
- By:
- Publication type:
- Article
Correction to: Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Peripheral CD8 T cell proliferation is prognostic for patients with advanced thoracic malignancies.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 3, p. 529, doi. 10.1007/s00262-012-1360-z
- By:
- Publication type:
- Article
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 8, p. 1219, doi. 10.1007/s00262-008-0628-9
- By:
- Publication type:
- Article
Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapy.
- Published in:
- Scientific Data, 2024, v. 11, n. 1, p. 1, doi. 10.1038/s41597-024-03294-0
- By:
- Publication type:
- Article
Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy.
- Published in:
- Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.00223
- By:
- Publication type:
- Article
How to Better Understand the Influence of Host Genetics on Developing an Effective Immune Response to Thoracic Cancers.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.679609
- By:
- Publication type:
- Article
Malignant Pleural Effusions—A Window Into Local Anti-Tumor T Cell Immunity?
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.672747
- By:
- Publication type:
- Article
Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: Persistent transgene expression despite antibody generation.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 5, p. 663, doi. 10.1038/sj.cgt.7700133
- By:
- Publication type:
- Article
Tumor Infiltrating Effector Memory Antigen-Specific CD8<sup>+</sup> T Cells Predict Response to Immune Checkpoint Therapy.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.584423
- By:
- Publication type:
- Article
Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance.
- Published in:
- Carcinogenesis, 2014, v. 35, n. 2, p. 407, doi. 10.1093/carcin/bgt322
- By:
- Publication type:
- Article
Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 501, p. 1, doi. 10.1126/scitranslmed.aav7816
- By:
- Publication type:
- Article
Voluntary exercise in mesothelioma: effects on tumour growth and treatment response in a murine model.
- Published in:
- BMC Research Notes, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13104-020-05284-y
- By:
- Publication type:
- Article
Oral antidiabetic agents.
- Published in:
- Nursing Standard, 2005, v. 19, n. 36, p. 105
- By:
- Publication type:
- Article
Insulin.
- Published in:
- Nursing Standard, 2005, v. 19, n. 32, p. 96
- By:
- Publication type:
- Article
Prescription drugs: uses and effects: Anticoagulants.
- Published in:
- Nursing Standard, 2005, v. 19, n. 19, p. 113
- By:
- Publication type:
- Article
Expression and integrity of DNA topoisomerase II isoforms does not explain generic drug resistance in malignant mesothelioma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Transient Treg depletion enhances therapeutic anti-cancer vaccination.
- Published in:
- Immunity, Inflammation & Disease, 2017, v. 5, n. 1, p. 16, doi. 10.1002/iid3.136
- By:
- Publication type:
- Article
Comment on "Drug Discovery: Turning the Titanic".
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 229, p. 1, doi. 10.1126/scitranslmed.3008763
- By:
- Publication type:
- Article
Neoadjuvant anti-tumor vaccination prior to surgery enhances survival.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/s12967-014-0245-7
- By:
- Publication type:
- Article
Neoadjuvant anti-tumor vaccination prior to surgery enhances survival.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations.
- Published in:
- Scientific Reports, 2015, p. 12298, doi. 10.1038/srep12298
- By:
- Publication type:
- Article
Immunological Events Underlying the Induction of T Cell Non-Responsiveness.
- Published in:
- International Archives of Allergy & Immunology, 1994, v. 104, n. 3, p. 211, doi. 10.1159/000236667
- By:
- Publication type:
- Article
Programmed Death Ligand 2 in Cancer-Induced Immune Suppression.
- Published in:
- Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/656340
- By:
- Publication type:
- Article
The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.
- Published in:
- Frontiers in Toxicology, 2024, p. 1, doi. 10.3389/ftox.2024.1373003
- By:
- Publication type:
- Article
Research Article CD4<sup>+</sup> T cells cross-compete for MHC class II-restricted peptide antigen complexes on the surface of antigen presenting cells.
- Published in:
- Immunology & Cell Biology, 2004, v. 82, n. 2, p. 103, doi. 10.1046/j.0818-9641.2004.01233.x
- By:
- Publication type:
- Article
Altered superantigenic ligands demonstrate the quantitative nature of T-cell activation.
- Published in:
- Immunology & Cell Biology, 2000, v. 78, n. 6, p. 623, doi. 10.1046/j.1440-1711.2000.00971.x
- By:
- Publication type:
- Article
Partial T cell activation with an altered superantigenic ligand.
- Published in:
- Immunology & Cell Biology, 2000, v. 78, n. 1, p. 13, doi. 10.1046/j.1440-1711.2000.00880.x
- By:
- Publication type:
- Article
Cross-presentation of tumour antigens: Evaluation of threshold, duration, distribution and regulation.
- Published in:
- Immunology & Cell Biology, 1999, v. 77, n. 6, p. 552, doi. 10.1046/j.1440-1711.1999.00876.x
- By:
- Publication type:
- Article
MHC multimerization, antigen expression and the induction of APC amnesia in the developing immune response.
- Published in:
- Immunology & Cell Biology, 1999, v. 77, n. 1, p. 99, doi. 10.1046/j.1440-1711.1999.00794.x
- By:
- Publication type:
- Article
A function for CD2 on murine B cells?
- Published in:
- Immunology & Cell Biology, 1997, v. 75, n. 4, p. 333, doi. 10.1038/icb.1997.51
- By:
- Publication type:
- Article
Tandem peptide epitopes facilitate CD4-dependent activation of T cell clones.
- Published in:
- Immunology & Cell Biology, 1997, v. 75, n. 2, p. 148, doi. 10.1038/icb.1997.20
- By:
- Publication type:
- Article
Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.960317
- By:
- Publication type:
- Article
Retinoic Acid Induces an IFN-Driven Inflammatory Tumour Microenvironment, Sensitizing to Immune Checkpoint Therapy.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.849793
- By:
- Publication type:
- Article
Bilateral murine tumor models for characterizing the response to immune checkpoint blockade.
- Published in:
- Nature Protocols, 2020, v. 15, n. 5, p. 1628, doi. 10.1038/s41596-020-0299-3
- By:
- Publication type:
- Article